BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 698907)

  • 1. The significance of mediastinal involvement in early stage Hodgkin's disease.
    Mauch P; Goodman R; Hellman S
    Cancer; 1978 Sep; 42(3):1039-45. PubMed ID: 698907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
    J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.
    Hughes-Davies L; Tarbell NJ; Coleman CN; Silver B; Shulman LN; Linggood R; Canellos GP; Mauch PM
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):361-9. PubMed ID: 9308940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
    Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
    Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is pelvic irradiation necessary in stage III1A Hodgkin's disease?
    Hartsell WF; Farah R; Murthy A; Golomb H; Weichselbaum R
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):715-9. PubMed ID: 2211220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation.
    Mauch P; Tarbell N; Weinstein H; Silver B; Goffman T; Osteen R; Zajac A; Coleman CN; Canellos G; Rosenthal D
    J Clin Oncol; 1988 Oct; 6(10):1576-83. PubMed ID: 3171625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease.
    Mauch P; Gorshein D; Cunningham J; Hellman S
    Cancer Treat Rep; 1982 Apr; 66(4):809-17. PubMed ID: 7074652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy in the management of bulky mediastinal Hodgkin's disease.
    Behar RA; Hoppe RT
    Cancer; 1990 Jul; 66(1):75-9. PubMed ID: 2354412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of stage II Hodgkin's disease with a large mediastinal mass: a prospective program emphasizing irradiation.
    Hoppe RT
    Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):349-55. PubMed ID: 3972653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of treatment of stage 3A Hodgkin's disease.
    Willett CG; Linggood RM; Meyer J; Orlow E; Lindfors K; Doppke K; Aisenberg AC
    Cancer; 1987 Jan; 59(1):27-30. PubMed ID: 3791147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement.
    Lu NN; Li YX; Wu RY; Zhang XM; Wang WH; Jin J; Song YW; Fang H; Ren H; Wang SL; Liu YP; Liu XF; Chen B; Dai JR; Yu ZH
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):210-6. PubMed ID: 22436783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of lung irradiation for Hodgkin's disease patient with large mediastinal masses and/or hilar disease.
    Lee CK; Bloomfield CD; Levitt SH
    Cancer Treat Rep; 1982 Apr; 66(4):819-25. PubMed ID: 7074653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can pelvic irradiation be omitted in patients with pathologic stages IA and IIA Hodgkin's disease?
    Goodman RL; Piro AJ; Hellman S
    Cancer; 1976 Jun; 37(6):2834-9. PubMed ID: 949703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modality treatment in adult stage I-II Hodgkin's disease with large mediastinal masses: study of 30 cases and review of the literature.
    Grigoraki V; Lilienthal F; Touboul E; Gabarre J; Binet JL; Merle-Béral H
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):437-45. PubMed ID: 8414965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment.
    Goodman R; Mauch P; Piro A; Rosenthal D; Goldstein M; Tullis J; Hellman S
    Cancer; 1977 Jul; 40(1):84-9. PubMed ID: 406981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of mediastinal mass in adult Hodgkin's disease.
    Schomberg PJ; Evans RG; O'Connell MJ; White WL; Banks PM; Ilstrup DM; Earle JD
    Cancer; 1984 Jan; 53(2):324-8. PubMed ID: 6690014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The residual mediastinal mass following radiation therapy for Hodgkin's disease.
    Glenn LD; Kumar PP
    Am J Clin Oncol; 1991 Feb; 14(1):16-24. PubMed ID: 1987732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.